Utz Herbig, Ph.D.
Associate Professor
Office: Cancer Center F1218
Tel: 973-972-4426
Lab: Cancer Center F Level Bay 10-11
Tel: 973-972-4424
Herbig NJMS Profile
|
RESEARCH:
Telomere Dysfunction-Induced Senescence in Aging, Cancer, and Tissue Repair
Over 60 years ago, it
was reported that human somatic cells cannot proliferate indefinitely and
instead undergo a stable proliferative arrest, called replicative senescence,
after dividing a finite number of times. It was suggested that this limited
proliferative capacity served one important purpose: to limit the growth of
cancer cells. As a side effect of these tumor-suppressing properties, however,
cellular senescence was also predicted to promote aging, as an inability to
proliferate extensively would increasingly prevent our cells from regenerating
and repairing tissue as we get older. Both predictions, however, remained
untested for decades because the molecular trigger of replicative senescence was
unknown. While my previous work identified dysfunctional telomeres as the
molecular switch that activated replicative senescence, work in my current laboratory
has provided evidence that telomere dysfunction-induced senescence (TDIS) contributes
to the aging of primates, revealed that TDIS acts as a tumor-suppressing
mechanism by restricting the proliferation of pre-malignant cancer cells, and
demonstrated a role for telomere dysfunction in wound healing and tissue repair.
My research program currently focuses on four major
areas: 1) causes of telomere shortening and dysfunction, 2) telomeres and
cellular senescence in tissue repair and cell plasticity, 3) telomeres and
cellular senescence in cancer development, and 4) telomeres and cellular
senescence in aging.
Selected Publications
·
Turano
PS, Akbulut E, Aquino NM, Garza-Martínez L, Singh S, Yap GS, Fitzgerald-Bocarsly P, Martínez-Zamudio RI, Herbig U. Senescent CD8 T Effector Memory Cells are
Functionally Impaired, Enriched in Aging and Disease, and a Barrier to
Immunotherapy. 2025. bioRxiv doi:
10.64898/2025.12.16.694716.
·
Turano
PS, Akbulut E, Dewald HK, Vasilopoulos T, Fitzgerald-Bocarsly P, Herbig U*, Martínez-Zamudio RI*. Age-independent
and targetable Transcription Factor Networks regulating CD8 T cells Senescence
in Aging Humans. 2026. Cell Reports, 45, 116795. *co-senior authors.
·
Ricardo
Iván Martínez-Zamudio, Alketa Stefa, José Américo Nabuco,
Themistoklis Vasilopoulos, Mark Simpson, Gregory Doré, Pierre-François Roux,
Mark A. Galan7, Ravi J. Chokshi, Oliver Bischof and Utz Herbig.
Escape From Oncogene-Induced Senescence is Controlled by POU2F2 and Memorized
by Chromatin Scars. 2023. Cell Genomics, 3, 100293
·
Ricardo
Iván Martínez-Zamudio1, Hannah K. Dewald1, Themistoklis
Vasilopoulos, Lisa Gittens-Williams, Patricia Fitzgerald-Bocarsly2,
and Utz Herbig2. 2021. Senescence-associated β-galactosidase
reveals the abundance of senescent CD8+ T cells in aging humans. Aging Cell.
e13344. 1co-1st authors; 2co-senior authors
·
Razdan
N, Vasilopoulos T, Herbig U. 2018 Telomere dysfunction promotes
transdifferentiation of human fibroblasts into myofibroblasts. Aging Cell 17:e12838.
·
Patel, P., Suram, A., Mirani, N., Bischof, O., Herbig, U.2016
Derepression of hTERT Gene Expression Promotes Escape from Oncogene-Induced
Cellular Senescence. PNAS; in press
·
Suram A, Kaplunov J, Patel PL, Ruan H,
Cerutti A, Boccardi V, Fumagalli M, Di Micco R, Mirani N, Gurung RL, Hande MP, d'Adda di Fagagna F, Herbig U.
2012. Oncogene-induced telomere dysfunction enforces cellular senescence in
human cancer precursor lesions. The EMBO Journal. 31: 2839-51
·
Fumagalli M, Rossiello F, Clerici M, Barozzi S, Cittaro D, Kaplunov JM, Bucci G,
Dobreva M, Matti V, Beausejour CM, Herbig U, Longhese MP, d'Adda di Fagagna F.
2012. Telomeric DNA damage is irreparable and causes persistent
DNA-damage-response activation. Nature Cell Biology 14: 355-65
·
Herbig, U., Ferreira, M., Condel, L.,
Carey, D. and Sedivy, J.M. 2006. Cellular senescence in aging primates. Science
311:1257
Awards
and Honors
2023 New
Jersey Medical School Mentoring Award
2023 Editorial
Board, Aging Biology (2018-present)
2018 Editorial
Board, Aging Cell (2018-2023)
2011 Member,
Cancer Institute of New Jersey (2011-present)
2010 American
Cancer Society Research Scholar Grant Award
2007 New Scholar Award; The Ellison Medical Foundation
2000 University Central Intramural Discovery Grant; Vanderbilt
University
Education
1999 Ph.D. in
Molecular Biology, Vanderbilt University, Nashville, TN
1995 Hauptdiplom (Masters of Science)
in Chemistry/Biochemistry, Ludwig Maximilians University, Munich, Germany
Positions
2013-present
Associate Professor, Microbiology, Biochemistry & Molecular Genetics,
Rutgers Biomedical and Health Sciences, Rutgers, The State University of New
Jersey
2006-2013
Assistant Professor, Microbiology & Molecular Genetics, University of
Medicine and Dentistry of New Jersey (UMDNJ)